Vistin Pharma ASA: Fourth quarter and preliminary 2023 financial results
February 16, 2024 01:45 ET
|
Vistin Pharma ASA
Oslo, Norway, 16th of February 2024 Vistin Pharma ASA (Vistin Pharma, OSE: VISTN) today announces the financial results for the fourth quarter of 2023. Vistin delivers another strong quarter with...
Vistin Pharma ASA: Invitation to Q4 2023 conference call
February 09, 2024 04:00 ET
|
Vistin Pharma ASA
Oslo, Norway, 9 February 2024 Vistin Pharma ASA will release its fourth quarter and preliminary 2023 results on Friday 16th of February 2024. Vistin Pharma will host a conference call for all...
Ex dividend NOK 0.75 today
January 23, 2024 02:00 ET
|
Vistin Pharma ASA
The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.75 as from today, 23.01.2024. ...
Key information relating to the cash dividend to be paid by Vistin Pharma ASA
January 11, 2024 05:40 ET
|
Vistin Pharma ASA
Dividend amount (per share): NOK 0.75 Declared currency: NOK Last day including right: 22 January 2024 Ex-date: 23 January 2024 Record date: 24 January 2024 Payment date: 30 January...
Vistin Pharma ASA: Dividend of NOK 0.75 per share
January 11, 2024 05:35 ET
|
Vistin Pharma ASA
Oslo, Norway, 11 January 2024 Norwegian pharmaceutical company Vistin Pharma ASA (“Vistin Pharma”) announced today that the Board has decided for a dividend of NOK 0.75 per share. The dividend is...
Vistin Pharma ASA: Third quarter 2023 financial results
October 25, 2023 01:45 ET
|
Vistin Pharma ASA
Oslo, Norway, 25th of October 2023 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the third quarter of 2023. Vistin delivers another strong quarter with...
Vistin Pharma ASA: New CEO appointed
October 25, 2023 01:45 ET
|
Vistin Pharma ASA
Oslo, Norway, 25th of October 2023 The Board of Directors of Vistin Pharma ASA has appointed Magnus Tolleshaug as the new CEO of Vistin Pharma from 1st of January 2024. Magnus Tolleshaug is...
Vistin Pharma ASA: Invitation to Q3 2023 conference call
October 18, 2023 07:00 ET
|
Vistin Pharma ASA
Oslo, Norway, 18 October 2023 Vistin Pharma ASA will release its third quarter results on Wednesday 25th of October 2023. Vistin Pharma will host a conference call for all shareholders and interested...
Vistin Pharma ASA: Mandatory notification of trade
September 18, 2023 12:40 ET
|
Vistin Pharma ASA
Saga Pure ASA has on 18 September 2023 purchased 100,000 shares in Vistin Pharma ASA at NOK 23,50 per share. After the transaction Saga Pure ASA has a holding of 100,000 shares, corresponding to 0.23...
Mandatory notification of trade in Vistin Pharma ASA
August 26, 2023 03:40 ET
|
Vistin Pharma ASA
Ferncliff Listed DAI AS has on 25 August 2023 purchased 200,000 shares in Vistin Pharma ASA at NOK 21 per share. After the transaction Ferncliff Listed DAI AS has a holding of 1,234,280 shares,...